Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Locations section with Illinois; removed the Illinois Locations listing and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T20:54:21.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision tag v3.3.2 was added and an earlier revision tag v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:30:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The notice about government funding status was removed from the page, and this does not affect the trial details, eligibility criteria, or outcomes listed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:09.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Updated the study status to Active, not recruiting with new milestone dates (e.g., 2025-11-05, 2026-03, 2025-11-03). Removed the PI note about cohorts closed for analysis and the suspended status along with several past dates (e.g., 2025-10-01, 2025-09, 2025-09-29).
    Difference
    0.4%
    Check dated 2025-11-11T02:13:19.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Study status updated to Suspended Per PI with cohorts closed for analysis. Enrollment is affected and ongoing access to study information may be limited.
    Difference
    0.4%
    Check dated 2025-11-03T20:41:35.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Updated operating-status notice and versioning: added a current funding/status banner and new date/revision (v3.2.0), while removing older date references and the previous revision (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T04:35:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.